Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generalizable structure-function covariation predictive of antidepressant response revealed by target-oriented multimodal fusion.

Nature. Mental health·2026
Same author

Rectangular Pulse Three-Hour Repetitive Transcranial Magnetic Stimulation Treatment for Major Depressive Disorder: A Pilot Trial.

Neuromodulation : journal of the International Neuromodulation Society·2026
Same author

Shared and specific associations of amygdala nuclei volumes with PTSD symptom domains and childhood trauma: An ENIGMA-PGC PTSD mega-analysis.

Molecular psychiatry·2026
Same author

Ibogaine in the Vet Brain: Changes in Brain Metabolism and Connectivity After Ibogaine Administration in Veterans With Traumatic Brain Injury.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026
Same author

Skin-attached bioadhesive patch enabling ultrasound deep brain stimulation and real-time electrophysiological monitoring for REM sleep enhancement.

Nature communications·2026
Same author

Childhood Maltreatment in the Context of Familial Bipolar I Disorder Risk Predicts Major Depressive Disorder in Adolescents.

JAACAP open·2026

Related Experiment Video

Updated: Jul 4, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.9K

Individual deviations from normative electroencephalographic connectivity predict antidepressant response.

Xiaoyu Tong1, Hua Xie2, Wei Wu3

  • 1Department of Bioengineering, Lehigh University, Bethlehem, PA, USA.

Journal of Affective Disorders
|January 28, 2024
PubMed
Summary

This study introduces a novel framework using resting-state EEG to predict antidepressant treatment response in major depressive disorder (MDD). The model accurately forecasts outcomes, paving the way for personalized MDD therapies.

Keywords:
AntidepressantEEGFunctional connectivityIndividual deviationMajor depressive disorderTreatment outcome

More Related Videos

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.3K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.6K

Related Experiment Videos

Last Updated: Jul 4, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

13.9K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.3K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

3.6K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Computational Biology

Background:

  • Major Depressive Disorder (MDD) treatment outcomes are often unsatisfactory due to unknown mechanisms and patient response variability.
  • Current antidepressant efficacy shows only modest advantages over placebo.
  • Personalized treatment approaches are needed for psychiatric disorders.

Purpose of the Study:

  • Develop a novel normative modeling framework to quantify individual deviations in psychopathological dimensions.
  • Enable personalized treatment strategies for psychiatric disorders like MDD.
  • Predict individual treatment responses to antidepressants.

Main Methods:

  • Constructed a normative model using resting-state electroencephalography (EEG) connectivity data from three healthy control cohorts.
  • Quantified individual deviations of MDD patients from healthy norms.
  • Trained sparse predictive models for treatment response using EEG data from 102 sertraline-medicated and 119 placebo-medicated patients, assessing Hamilton Depression Rating Scale (HAMD-17) changes over eight weeks.

Main Results:

  • Successfully predicted treatment outcomes for both sertraline (r=0.43, p<0.001) and placebo (r=0.33, p<0.001) groups.
  • Demonstrated the framework's ability to distinguish subclinical and diagnostic variability.
  • Identified key resting-state EEG connectivity signatures linked to antidepressant treatment response, highlighting differential neural circuit involvement.

Conclusions:

  • The developed normative modeling framework advances neurobiological understanding of antidepressant response pathways.
  • The findings support the potential for more targeted and effective personalized MDD treatment.
  • The generalizable framework offers a promising avenue for precision medicine in psychiatry.